Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Neoplasms 1Hypogonadism 1Fatigue 1Eunuchism 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Therapeutics 2enzalutamide 1dexamethasone acetate 1dexamethasone 21-phosphate 1darolutamide 1auricularum 1apalutamide 1Therapeutic Touch 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sildenafil Citrate 1Relaxation Therapy 1Radiotherapy 1Methods 1Gels 1Exercise Test 1Exercise 1Electroacupuncture 1Educational Status 1Early Intervention, Educational 1Diet Therapy 1Dexamethasone 1Counseling 1Consolidation Chemotherapy 1Cognitive Behavioral Therapy 1Chemoradiotherapy 1Calcium Dobesilate 1Acupressure 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Testosterone × 90 days × Clear all
NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting
230 enrolled

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡